Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 5.21% |
| CYNOSURE INC | CYNO | 4.42% |
| DAWSON GEOPH | DWSN | 4.33% |
| MARRIOT VAC | VAC | 3.27% |
| BLOOMIN BRAN | BLMN | 2.93% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Leggett & Platt Inc. (LEG - Analyst Report), the manufacturer of diversified engineered products and components, posted a flat year-over-year earnings of 30 cents per share for first-quarter 2012, missing the Zacks Consensus Estimate of 32 cents. Benefits from increased sales were fully offset by higher tax rate, resulting in flat year-over-year earnings growth.
Total sales in the quarter climbed 5.7% to $946.8 million compared with $895.8 million a year ago, benefitting from the acquisition of Western Pneumatic Tube and increased same-location sales. The company’s quarterly sales also rose above the Zacks Consensus Estimate of $928 million. Same-location sales increased 4.5%, driven by unit volume and inflation.
Segment Revenue
Residential Furnishings revenue for the first quarter climbed 7.1% to $492.6 million driven by 2% increase in inflation and a 5% rise in unit volume. However, operating income declined 5% to $40.2 million compared with $42.1 million in the prior-year quarter as the benefit from increased sales were more than offset by higher raw material costs and unfavorable product mix.
Sales of Commercial Fixturing & Components moved down 11.5% to $114.2 million, primarily due to divesture and an 8% decline in same location sales. Consequently, operating income during the quarter decreased 12% to $7.2 million compared with $8.2 million in the prior-year quarter.
First quarter sales for the Industrial Materials segment was up 13% to $237.7 million backed by higher inflation, benefit from acquisition of Western Pneumatic Tube and higher same location sales, partially offset by a 1% decline in unit volume. Conversely, operating income declined 16%, primarily due to some adjustment regarding the acquisition of Western Pneumatic Tube.
Specialized Products segment witnessed growth of 6% to $185.3 million in the first quarter. However, operating income inched down 1% to $17.9 million compared with $18.1 million.
Margins
Gross profit for the quarter grew 4.9% to $178.3 million, while gross margin contracted 20 basis points to 18.8%, mainly due to higher cost of goods sold. Operating income remains almost flat at $74.6 million compared with $74.2 million in the prior-year quarter. However, operating margin shrunk 40 basis points to 7.9% due to a 2% increase in selling & administrative expenses and lower gross margin.
Other Financial Details
Leggett exited the first quarter of fiscal 2012 with cash and equivalents of $261.2 million, long-term debt of $1,046.8 million, and shareholders' equity of $1,343.2 million. During the quarter, the company generated $65.1 million cash from operations and paid $39 million toward dividend and $2.5 million to buy back the company’s shares.
Guidance
Going forward, the company expects to gain momentum as the economy expands. Anticipating a modest economic recovery in 2012, the company has raised its sales forecast for the fiscal in the range of $3.65-$3.85 billion instead of $3.6-$3.8 billion anticipated earlier. Further, the company forecasts earnings per share between $1.25 and $1.45 for 2012, up from $1.20-$1.40 guided earlier.
For 2012, the company expects to generate more than $325 million in cash from operations instead of its previous expectation of $300 million, with capital spending and dividends estimated at about $100 million and $160 million, respectively. Further, the company remains open to capture acquisition opportunities that fit its strategy and meet its criteria.
Leggett faces stiff competition from its rivals, such as Flexsteel Industries Inc. (FLXS), Genuine Parts Company (GPC - Analyst Report) and Steelcase Inc. (SCS - Snapshot Report). The company currently retains a Zacks #4 Rank, which translates to a short-term Sell rating.
Moreover, we remain cautious on the stock and uphold our long-term Underperform recommendation. At this stage, our caution is guided by the company's history of missing the Zacks Consensus Estimate and we wait to see further catalysts before becoming more positive on the stock.
Read the full reports :
Analyst Report on LEG
Analyst Report on GPC
on FLXS
Snapshot Report on SCS